NCT05442814

Brief Summary

Suprascapular nerve is a mixed motor and sensory peripheral nerve arising from the superior trunk of brachial plexus.The suprascapular nerve runs through the posterior triangle of the neck, anterior of the trapezius muscle and dorsal of the omohyoid muscle, in direction of the scapula. Suprascapular nerve block is performed by anterior and posterior approach. Posterior approach of the suprascapular nerve block has been shown for many years to provide effective analgesia in the shoulder region for the chronic and acute pain. There are studies showing that suprascapular block with anterior approach provides effective analgesia in shoulder arthroscopy. The aim of our study was to compare anterior and posterior approaches of suprascapular nerve block in terms of analgesic efficacy and patient safety.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 5, 2022

Completed
6 days until next milestone

Study Start

First participant enrolled

July 11, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2023

Completed
Last Updated

February 23, 2026

Status Verified

February 1, 2026

Enrollment Period

11 months

First QC Date

April 18, 2022

Last Update Submit

February 19, 2026

Conditions

Keywords

Shoulder painNerve BlockDiaphragmatic paralysisPostoperative painSuprascapular blockSubomohyoid suprascapular blockPosterior Suprascapular blockAnterior Suprascapular block

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain at the postoperatively 30 Minutes, 4 Hours, 6Hours, 12Hours, 24Hours

    Visual analogue scale (0-10): 0= no pain, 10= the worst pain ever feel.

    Up to 24 hours post-operative

Secondary Outcomes (11)

  • Diaphragmatic movements

    Baseline (Before the block performed) and 30 minutes after the end of surgery

  • Peroperatively opioid analgesic consumption (Remifentanil)

    up to postoperative 0 minutes

  • Postoperative opioid analgesic consumption (morphine)

    postoperative 30 minutes

  • Postoperative opioid analgesic consumption (morphine)

    postoperative 4 hours

  • Postoperative opioid analgesic consumption (morphine)

    postoperative 6 hours

  • +6 more secondary outcomes

Study Arms (2)

Posterior suprascapular block

ACTIVE COMPARATOR

Suprascapular block performed by posterior approach

Procedure: Posterior suprascapular block

Anterior suprascapular block

ACTIVE COMPARATOR

Suprascapular block performed by anterior approach

Procedure: Anterior suprascapular block

Interventions

Diaphragmatic thickness fraction will be evaluated in the participant underwent suprascapular block performed by posterior approach

Posterior suprascapular block

Diaphragmatic thickness fraction will be evaluated in the participant underwent suprascapular block performed by anterior approach

Anterior suprascapular block

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient who accepts to study protocol
  • Scheduled for shoulder surgery
  • Between the ages of 18 and 80

You may not qualify if:

  • Patients with coagulopathy
  • Patients with a history of local anesthetic drug allergy and toxicity
  • Patients with advanced organ failure
  • Patients with mental retardation
  • Patients with infection present at the injection site
  • Patients with diaphragm paralysis
  • Pregnant patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Medeniyet University

Istanbul, 34722, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Shoulder PainPain, PostoperativeRespiratory Paralysis

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesRespiratory InsufficiencyRespiration DisordersRespiratory Tract DiseasesParalysisNervous System Diseases

Study Officials

  • Ebru Girgin Dinç, MD

    İstanbul Medeniyet University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
sealed envelope
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: participant with anterior suprascapular block ,group 1 participant with posterior suprascapular block, group 2
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 18, 2022

First Posted

July 5, 2022

Study Start

July 11, 2022

Primary Completion

June 15, 2023

Study Completion

July 15, 2023

Last Updated

February 23, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

After the article is accepted by the journal

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
After the article is accepted by the journal
Access Criteria
After the article is accepted by the journal

Locations